Please try another search
Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Anshun, China.
Name | Age | Since | Title |
---|---|---|---|
Min Niu | 53 | 2007 | GM, Secretary & Director |
Yong Jiang | 55 | 2007 | Director |
Wen Xia | 54 | 2000 | Chairman of the Supervisory Board and R&D Director |
Dong Long | 47 | 2020 | Shareholder Supervisor |
Yifeng Zhou | 49 | 2022 | Director |
Shengqiang Liu | 45 | 2020 | Independent Director |
Jian Hu | 55 | 2020 | Independent Director |
Qiang Li | 44 | 2014 | Member of the Supervisory Board |
Pei Chen | 38 | 2013 | Deputy GM & Director |
Wei Jiang | 62 | 2007 | Chairman |
Xuchen Sun | 33 | 2019 | Shareholder Supervisor |
Hongwu Zhang | - | 2023 | Independent Director |
Chungang Zhou | - | 2023 | Shareholder Supervisor |
Kai Song | 40 | 2021 | Shareholder Supervisor |
Ming Yang | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review